novo glp 1 drugs With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss begins Novo, Lilly Stocks Rise. Weight-Loss

Bone Health Concerns (Osteoporosis) One of the most serious but under-discussed long-term risks of GLP-1 medications is their potential impact on bone health

Even short-term changes in treatment may have meaningful implications for patients as they navigate the impact of formulary decisions

Morning application ensures consistent daily use for those who sometimes skip evening skincare

Li Y, Xing L, Wang L et al (2023) Milk-derived exosomes as a promising vehicle for oral delivery of hydrophilic biomacromolecule drugs

In some cases, this approach makes sense for example, using laser lipo for areas where skin tightening is important (like the abdomen or arms) while using non-invasive methods for smaller trouble spots